AlphaMaven AlphaMaven

Venture capital poured into medical and healthcare startups integrating AI

Reported by Mt
Nov 22, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • Mediintech raised 33.8 billion won in a Series C round, bringing its cumulative funding to 62.2 billion won, with Atinum Investment and KB Investment co-leading the round, according to MoneyToday.
  • • Sumbit AI raised 12 billion won in a Series A round led by SV Investment, Altor Ventures, Kiwoom Investment, and iM Investment Partners for its generative AI medical image diagnosis platform.
  • • Venture capital in Korea's medical sector during November 16-20 was concentrated in AI-integrated healthcare businesses, such as AI robotic endoscopes and medical image diagnosis, rather than traditional drug development.
  • • WINNER S Electric acquired a 10.52% stake in wearable robotics startup Hexarobotics for 4 billion won, becoming its second-largest shareholder, alongside an exclusive OEM contract.
  • • Corporate and CVC investors, including Hyosung Ventures and Samchully Group, were active participants in the week's deals, with Hyosung Ventures investing in digital healthcare startup Soldoc.
Summary
South Korea's domestic venture capital market recorded a series of medical and healthcare investments during the third week of November (November 16-20), according to MoneyToday. Most capital was directed toward healthcare businesses integrating artificial intelligence, including AI-driven endoscopic robots, AI-based medical image diagnosis, and personalized healthcare solutions, rather than traditional biotech fields such as new drug development. Strategic investments and corporate venture capital (CVC) deals were also frequent during the period. Companies announcing fundraising included Mediintech, Extol, Hexarobotics, Sumbit AI, Sacak, Mannyfast, Oncovision AI, AABC Bio, Proground, At Home, Soldoc, Skybridge Global, Coils, and Nubinda.

Mediintech, a medical robotics startup founded in 2020, raised 33.8 billion won in a Series C round, bringing its cumulative investment to 62.2 billion won. The round was co-led by existing investor Atinum Investment and new investor KB Investment, with participation from Smilegate Investment, SL Investment, ICF (Nextlance), and Woo Shin Venture Investment, while K2 Investment Partners joined as a new investor. The company said it is discussing additional investment for the round. Its flagship product, 'Intion S,' is an AI robotic endoscope that uses motor-based precision control in place of manual wire operation. CEO Lee Chi-won said the company will expand domestic and international supply and advance autonomous steering and precision control toward a medical robotics platform spanning diagnosis, treatment, and surgery.

Sumbit AI, which provides generative AI-based medical image diagnosis, raised 12 billion won in a Series A round from SV Investment, Altor Ventures, Kiwoom Investment, and iM Investment Partners. Established in July 2024 by a team that developed chest X-ray diagnostic AI at Kakao Brain, the company is led by CEO Bae Woong, formerly Chief Healthcare Officer at Kakao Brain. Its flagship product, AIRead-CXR, automatically drafts chest X-ray reports covering at least 57 findings and received Class III digital medical device approval from the Ministry of Food and Drug Safety in April. The company describes it as the first domestically approved generative AI software as a medical device that directly analyzes medical images to produce preliminary reports. Bae said the company will expand to CT and MRI.

In a separate strategic deal, WINNER S Electric invested 4 billion won in wearable robotics startup Hexarobotics, taking a 10.52% stake and becoming its second-largest shareholder. The two companies had signed a strategic partnership and exclusive OEM contract for wearable robot product lines in October, under which WINNER S Electric will handle mass production process setup, core module production, assembly, and shipment inspection for walking-assist robots.

Hyosung Ventures, the CVC of Hyosung Group, invested in digital healthcare startup Soldoc and beauty tech company At Home through its second 'Startup Korea Hyosung Deep Tech Investment Fund,' established with Korea Venture Investment in 2024 and targeting AI and bio. Samchully Group also selected robotics-focused startups Nubinda and Coils for its 'S-Together' open innovation program, with investments to follow; more than 100 companies applied to the program this year.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Mt Venture capital poured into medical and healthcare startups integrating AI